rs143722284
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 1P and 11B. PP3BP4_ModerateBP6BS1BS2
The NM_018060.4(IARS2):c.2122G>A(p.Glu708Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,614,100 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018060.4 missense
Scores
Clinical Significance
Conservation
Publications
- cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndromeInheritance: AR, Unknown Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IARS2 | NM_018060.4 | c.2122G>A | p.Glu708Lys | missense_variant | Exon 17 of 23 | ENST00000366922.3 | NP_060530.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000940 AC: 143AN: 152144Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00127 AC: 319AN: 251460 AF XY: 0.00134 show subpopulations
GnomAD4 exome AF: 0.00113 AC: 1653AN: 1461838Hom.: 7 Cov.: 30 AF XY: 0.00118 AC XY: 858AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000933 AC: 142AN: 152262Hom.: 1 Cov.: 33 AF XY: 0.00110 AC XY: 82AN XY: 74452 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:3
- -
- -
IARS2: BS2 -
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30419932, 30041933, 25130867, 34426522, LopesBragaV2023[article], 33972171, 39062673) -
Leigh syndrome Pathogenic:1
- -
not specified Benign:1
Variant summary: IARS2 c.2122G>A (p.Glu708Lys) results in a conservative amino acid change located in the Aminoacyl-tRNA synthetase, class Ia domain (IPR002300) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0013 in 251460 control chromosomes, predominantly at a frequency of 0.003 within the South Asian subpopulation in the gnomAD database, including 4 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database exceeds the estimated maximal expected allele frequency for a pathogenic variant in IARS2 causing Cataract-Growth Hormone Deficiency-Sensory Neuropathy-Sensorineural Hearing Loss-Skeletal Dysplasia Syndrome phenotype. c.2122G>A has been reported in the literature in the presumed compound heterozygous state in multiple individuals affected with clinical features of IARS2-related conditions, however the the population frequency of this variant is not in pathogenic range. These report(s) do not provide unequivocal conclusions about association of the variant with IARS2-related conditions. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33327715, 33972171, 25130867). ClinVar contains an entry for this variant (Variation ID: 156552). Based on the evidence outlined above, the variant was classified as likely benign. -
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at